Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Miklos Degré

210 publications found

Original articles

Buzás K, Miczák A, Degré M, Megyeri K (2004)
Rubella virus infection dysregulates the pattern of p63 expression
APMIS, 112 (10), 656-62
DOI 10.1111/j.1600-0463.2004.apm1121004.x, PubMed 15601317

Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
Kidney Int, 66 (1), 329-37
DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441

Buzás K, Megyeri K, Miczák A, Fekete A, Degré M, Mándi Y, Rosztóczy I (2004)
Different staphylococcal strains elicit different levels of production of T-helper 1-inducing cytokines
Acta Microbiol Immunol Hung, 51 (3), 371-84
DOI 10.1556/AMicr.51.2004.3.14, PubMed 15571076

Nordøy I, Rollag H, Lien E, Sindre H, Degré M, Aukrust P, Frøland SS, Müller F (2003)
Cytomegalovirus infection induces production of human interleukin-10 in macrophages
Eur J Clin Microbiol Infect Dis, 22 (12), 737-41
DOI 10.1007/s10096-003-1028-x, PubMed 14610657

Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
Nephrol Dial Transplant, 18 (9), 1899-908
DOI 10.1093/ndt/gfg302, PubMed 12937241

Moen EM, Sagedal S, Bjøro K, Degré M, Opstad PK, Grinde B (2003)
Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia
J Med Virol, 70 (1), 177-82
DOI 10.1002/jmv.10356, PubMed 12629661

Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
Am J Transplant, 2 (9), 850-6
DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291

Megyeri K, Mándi Y, Degré M, Rosztóczy I (2002)
Induction of cytokine production by different Staphylococcal strains
Cytokine, 19 (4), 206-12
DOI 10.1006/cyto.2002.0876, PubMed 12297115

Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
Clin Microbiol Infect, 8 (7), 431-4
DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854

Degré M, Ranneberg-Nilsen T, Beck S, Rollag H, Fiane AE (2001)
Human cytomegalovirus productively infects porcine endothelial cells in vitro
Transplantation, 72 (7), 1334-7
DOI 10.1097/00007890-200110150-00028, PubMed 11602867

Degré M, Kristiansen KI, Rollag H, Holter E, Nordal KP (2001)
Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients
Clin Microbiol Infect, 7 (5), 254-60
DOI 10.1046/j.1198-743x.2001.00251.x, PubMed 11422252

Moens U, Van Ghelue M, Kristoffersen AK, Johansen B, Rekvig OP, Degré M, Rollag H (2001)
Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoter
Virus Genes, 23 (2), 215-26
DOI 10.1023/a:1011877112214, PubMed 11724277

Andenaes S, Lie A, Degré M (2000)
Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel
Aviat Space Environ Med, 71 (12), 1178-80
PubMed 11439715

Sagedal S, Nordal KP, Hartmann A, Degré M, Holter E, Foss A, Osnes K, Leivestad T, Fauchald P, Rollag H (2000)
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients
Transplantation, 70 (8), 1166-74
DOI 10.1097/00007890-200010270-00007, PubMed 11063335

Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
Scand J Immunol, 51 (4), 354-60
DOI 10.1046/j.1365-3083.2000.00676.x, PubMed 10736107

Sindre H, Rollag H, Olafsen MK, Degré M, Hestdal K (2000)
Human cytomegalovirus induces apoptosis in the hematopoietic cell line MO7e
APMIS, 108 (3), 223-30
DOI 10.1034/j.1600-0463.2000.d01-48.x, PubMed 10752692

Sindre H, Rollag H, Degré M, Hestdal K (2000)
Human cytomegalovirus induced inhibition of hematopoietic cell line growth is initiated by events taking place before translation of viral gene products
Arch Virol, 145 (1), 99-111
DOI 10.1007/s007050050008, PubMed 10664409

Bruun T, Kristoffersen AK, Rollag H, Beck S, Degré M (1998)
Herpes simplex virus type 1 inhibits in vitro differentiation and selected functions of human blood-derived monocytes
APMIS, 106 (12), 1194-203
DOI 10.1111/j.1699-0463.1998.tb00277.x, PubMed 10052729

Flugsrud LB, Degré M (1998)
[Poliomyelitis--the beginning of the end]
Tidsskr Nor Laegeforen, 118 (13), 1997-8
PubMed 9656781

Bruun T, Kristoffersen AK, Rollag H, Degré M (1998)
Interaction of herpes simplex virus with mononuclear phagocytes is dependent on the differentiation stage of the cells
APMIS, 106 (2), 305-14
DOI 10.1111/j.1699-0463.1998.tb01351.x, PubMed 9531964

Rollag H, Sagedal S, Holter E, Degré M, Ariansen S, Nordal KP (1998)
Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes
Eur J Clin Microbiol Infect Dis, 17 (2), 124-7
DOI 10.1007/BF01682170, PubMed 9629980

Kristoffersen AK, Johnsen JI, Seternes OM, Rollag H, Degré M, Traavik T (1997)
The human polyomavirus BK T antigen induces gene expression in human cytomegalovirus
Virus Res, 52 (1), 61-71
DOI 10.1016/s0168-1702(97)00100-7, PubMed 9453145

Kristoffersen AK, Sindre H, Mándi Y, Rollag H, Degré M (1997)
Effect of adenovirus 2 on cellular gene activation in blood-derived monocytes and macrophages
APMIS, 105 (5), 402-9
DOI 10.1111/j.1699-0463.1997.tb00587.x, PubMed 9201242

Holberg-Petersen M, Rollag H, Beck S, Degré M (1997)
The effect of human cytomegalovirus on selected functions of peripheral blood monocytes
APMIS, 105 (2), 89-98
DOI 10.1111/j.1699-0463.1997.tb00546.x, PubMed 9113070

Holberg-Petersen M, Høgåsen AK, Høgåsen K, Abrahamsen TG, Degré M, Rollag H (1997)
Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3
Arch Virol, 142 (4), 689-98
DOI 10.1007/s007050050111, PubMed 9170497

Sindre H, Tjøonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degré M, Hestdal K (1996)
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells
Blood, 88 (12), 4526-33
DOI 10.1182/blood.V88.12.4526.bloodjournal88124526, PubMed 8977244

Holberg-Petersen M, Rollag H, Beck S, Overli I, Tjønnfjord G, Abrahamsen TG, Degré M, Hestdal K (1996)
Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro
Blood, 88 (7), 2510-6
DOI 10.1182/blood.V88.7.2510.bloodjournal8872510, PubMed 8839843

Holberg-Petersen M, Bukholm G, Haarr L, Langeland N, Degré M (1996)
Human interferon reduces surface expression but not total production of herpes simplex virus type 1 glycoproteins gC and gE in heterologous hamster cells
J Interferon Cytokine Res, 16 (9), 717-24
DOI 10.1089/jir.1996.16.717, PubMed 8887056

Dousset N, Moatti JP, Moatti N, Degré M, Eche B, Gasset G, Tixador R (1996)
Influence of the environment in space on the biochemical characteristics of human low density lipoproteins
Free Radic Res, 24 (1), 69-74
DOI 10.3109/10715769609088001, PubMed 8747894

Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS (1996)
The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency
APMIS, 104 (7-8), 539-48
DOI 10.1111/j.1699-0463.1996.tb04909.x, PubMed 8920807

Degré M (1996)
Cytokines and bacterial infections
Biotherapy, 8 (3-4), 219-28
DOI 10.1007/BF01877208, PubMed 8813334

Degré M (1995)
[Infectious diseases--new and old, in new forms]
Tidsskr Nor Laegeforen, 115 (23), 2875-6
PubMed 7570504

Modalsli KR, Bukholm G, Holberg-Petersen M, Degré M (1995)
Shigella flexneri adherence to and multiplication in coxsackie B1 virus-infected HEp-2 cells
APMIS, 103 (4), 254-60
DOI 10.1111/j.1699-0463.1995.tb01103.x, PubMed 7612255

Moatti JP, Dousset N, Moatti N, Degre M, Eche B, Gasset G, Tixador R (1995)
ESA's Biopan 1--"Vitamin" experiment preliminary results
Acta Astronaut, 36 (8-12), 527-33
DOI 10.1016/0094-5765(95)00138-7, PubMed 11540984

Dueland AN, Ranneberg-Nilsen T, Degré M (1995)
Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization
Arch Virol, 140 (11), 2055-66
DOI 10.1007/BF01322692, PubMed 7503701

Degré M, Bukholm G (1995)
Orally administered interferon-gamma but not tumor necrosis factor-alpha suppress infection with Salmonella typhimurium in a mouse model
J Biol Regul Homeost Agents, 9 (1), 15-20
PubMed 8553903

Holberg-Petersen M, Bukholm G, Rollag H, Degré M (1994)
Infection with human cytomegalovirus enhances bacterial adhesiveness and invasiveness in permissive and semipermissive cells
APMIS, 102 (9), 703-10
DOI 10.1111/j.1699-0463.1994.tb05223.x, PubMed 7946274

Degré M, Beck S (1994)
Anti-HIV activity of dideoxynucleosides, foscarnet and fusidic acid is potentiated by human leukocyte interferon in blood-derived macrophages
Chemotherapy, 40 (3), 201-8
DOI 10.1159/000239193, PubMed 7515781

TIGALONOVA M, BJERKE JR, GALLATI H, DEGRE M, JABLONSKA S, MAJEWSKI S, MATRE R (1994)
SERUM LEVELS OF INTERFERONS AND TNF-ALPHA ARE NOT CORRELATED TO PSORIASIS ACTIVITY AND THERAPY
Acta Derm.-Venereol., 74 186, 25-27

Tigalonova M, Bjerke JR, Gallati H, Degré M, Jablonska S, Majewski S, Matre R (1994)
Serum levels of interferons and TNF-alpha are not correlated to psoriasis activity and therapy
Acta Derm Venereol Suppl (Stockh), 186, 25-7
DOI 10.2340/000155551862527, PubMed 8073829

Modalsli KR, Mikalsen SO, Bukholm G, Degré M (1993)
Microinjection of HEp-2 cells with coxsackie B1 virus RNA enhances invasiveness of Shigella flexneri only after prestimulation with UV-inactivated virus
APMIS, 101 (8), 602-6
DOI 10.1111/j.1699-0463.1993.tb00153.x, PubMed 8217113

Stenseth AM, Rollag H, Degré M (1993)
Effect of in vitro acyclovir treatment on selected functions of blood-derived macrophages
Chemotherapy, 39 (3), 197-202
DOI 10.1159/000239126, PubMed 8508690

Degré M (1992)
[Prevention and treatment of influenza]
Tidsskr Nor Laegeforen, 112 (16), 2052
PubMed 1523619

Degré M, Beck S, Rollag H (1992)
Interferon-gamma may enhance infection of blood-derived macrophages with HIV-1 in the presence of HIV-positive serum
APMIS, 100 (5), 465-9
DOI 10.1111/j.1699-0463.1992.tb00898.x, PubMed 1586484

Modalsli K, Bukholm G, Mikalsen SO, Degré M (1992)
Correlation between Coxsackie B1 virus replication and enhanced invasiveness of Shigella flexneri
APMIS, 100 (3), 237-45
DOI 10.1111/j.1699-0463.1992.tb00866.x, PubMed 1314061

Modalsli K, Bukholm G, Degré M (1992)
Interferon treatment reduced adherence, invasiveness and intracellular multiplication of Shigella flexneri in coxsackie B1 virus-infected cells
J Biol Regul Homeost Agents, 6 (2), 35-45
PubMed 1329437

Müller F, Holberg-Petersen M, Rollag H, Degré M, Brandtzaeg P, Frøland SS (1992)
Nonspecific oral immunity in individuals with HIV infection
J Acquir Immune Defic Syndr (1988), 5 (1), 46-51
PubMed 1371157

Modalsli K, Bukholm G, Mikalsen SO, Degré M (1992)
Coxsackie B1 virus-induced changes in cell membrane-associated functions are not responsible for altered sensitivity to bacterial invasiveness
Arch Virol, 124 (3-4), 321-32
DOI 10.1007/BF01309812, PubMed 1318709

Degré M, Rollag H, Holter E, Tønjum T, Krajci Z, Bukholm G (1991)
[Diagnosis of cytomegalovirus infections in hospitalized patients]
Tidsskr Nor Laegeforen, 111 (28), 3401-4
PubMed 1665258

Degré M (1991)
[Virologic rapid diagnosis]
Tidsskr Nor Laegeforen, 111 (15), 1866
PubMed 1853322

Holberg-Petersen M, Böhmer E, Namork E, Degré M (1991)
Effect of interferon treatment on expression of gC and gE glycoproteins in herpes simplex virus-infected cells
APMIS, 99 (4), 307-15
DOI 10.1111/j.1699-0463.1991.tb05154.x, PubMed 1645168

Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A (1991)
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools
Scand J Infect Dis, 23 (6), 675-9
DOI 10.3109/00365549109024292, PubMed 1815327

Mándi Y, Endrész V, Krenács L, Régely K, Degré M, Béládi I (1991)
Tumor necrosis factor production by human granulocytes
Int Arch Allergy Appl Immunol, 96 (2), 102-6
DOI 10.1159/000235479, PubMed 1769740

Degré M (1990)
[Latent and activated viral infections]
Tidsskr Nor Laegeforen, 110 (21), 2747-8
PubMed 2219044

Modalsli K, Bukholm G, Degré M (1990)
Coxsackie B1 virus infection enhances the bacterial invasiveness, the phagocytosis and the membrane permeability in HEp-2 cells
APMIS, 98 (6), 489-95
DOI 10.1111/j.1699-0463.1990.tb01061.x, PubMed 2166540

Dahl-Hansen E, Siebke JC, Frøland SS, Degré M (1990)
Immunogenicity of yeast-derived hepatitis B vaccine from two different producers
Epidemiol Infect, 104 (1), 143-9
DOI 10.1017/s0950268800054625, PubMed 2137785

Bukholm G, Degré M, Whitaker-Dowling P (1990)
Interferon treatment reduces endocytosis of virus and facultatively intracellular bacteria in various cell lines
J Interferon Res, 10 (1), 83-9
DOI 10.1089/jir.1990.10.83, PubMed 1691770

Degré M, Bukholm G (1990)
Effect of tumor necrosis factor-alpha on infection with Salmonella typhimurium in a mouse model
J Biol Regul Homeost Agents, 4 (4), 157-61
PubMed 2128989

Maehlen T, Degré M (1989)
Lack of activity of fusidic acid against human immunodeficiency virus in monocytes
Antimicrob Agents Chemother, 33 (5), 680-3
DOI 10.1128/AAC.33.5.680, PubMed 2473711

Rollag H, Degré M (1989)
Phagocytic activity and protein content of human monocytes cultivated in the presence of various homologous interferon preparations
J Biol Regul Homeost Agents, 3 (1), 39-44
PubMed 2472044

Degré M, Bukholm G, Czarniecki CW (1989)
In vitro treatment of HEp-2 cells with human tumor necrosis factor-alpha and human interferons reduces invasiveness of Salmonella typhimurium
J Biol Regul Homeost Agents, 3 (1), 1-7
PubMed 2472042

Skar AG, Middeldorp J, Gundersen T, Rollag H, Degrè M (1988)
Rapid diagnosis of genital herpes simplex infection by an indirect ELISA method
NIPH Ann, 11 (2), 59-65
PubMed 3247065

Bukholm G, Bergh M, Degré M (1988)
Interferon treatment of HEp-2 cells alters the adhesive ability of Pseudomonas aeruginosa
APMIS, 96 (11), 1043-8
DOI 10.1111/j.1699-0463.1988.tb00979.x, PubMed 2461717

Oftung F, Mustafa AS, Shinnick TM, Houghten RA, Kvalheim G, Degre M, Lundin KE, Godal T (1988)
Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells
J Immunol, 141 (8), 2749-54
PubMed 2459228

Bukholm G, Bjørnland K, Ellekjaer H, Berdal BP, Degré M (1988)
Vesicular stomatitis virus infection enhances invasiveness of Salmonella typhimurium
APMIS, 96 (5), 400-6
DOI 10.1111/j.1699-0463.1988.tb05322.x, PubMed 2837253

Rollag H, Degré M (1988)
Effect of recombinant interferon-gamma on protein content, phagocytic, and cytotoxic activity of mouse peritoneal macrophages
J Interferon Res, 8 (2), 169-78
DOI 10.1089/jir.1988.8.169, PubMed 3132510

Degré M, Bukholm G (1988)
Effects of interferon and tumour necrosis factor on development of intracellular bacterial infections
Acta Microbiol Hung, 35 (4), 405-10
PubMed 2469282

Ekgren J, Norling BK, Degre M, Midtvedt T (1988)
Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis
Gynecol Obstet Invest, 26 (4), 313-7
DOI 10.1159/000293712, PubMed 3068098

Livden JK, Bjerke JR, Degre M, Matre R (1987)
Effect of UV radiation on interferon, immunoglobulins and complement components in serum from healthy individuals
Photodermatol, 4 (6), 296-301
PubMed 2451236

Bukholm G, Bergh M, Degré M (1987)
Interferon-induced protein synthesis inhibits endocytosis of bacteria in epithelial cells
J Interferon Res, 7 (4), 409-17
DOI 10.1089/jir.1987.7.409, PubMed 3312425

Austgulen R, Nissen-Meyer J, Degré M, Espevik T (1987)
Monocyte-derived influence on growth of normal human fibroblasts. The contribution of tumour necrosis factor to growth inhibition
Scand J Immunol, 26 (2), 175-85
DOI 10.1111/j.1365-3083.1987.tb02249.x, PubMed 3114873

Livden JK, Bjerke JR, Degre M, Krogh HK, Matre R (1987)
The significance of interferon in photoimmunology
Acta Derm Venereol Suppl (Stockh), 134, 43-6
PubMed 2451386

Bukholm G, Modalsli K, Degré M (1986)
Effect of measles-virus infection and interferon treatment on invasiveness of Shigella flexneri in HEp2-cell cultures
J Med Microbiol, 22 (4), 335-41
DOI 10.1099/00222615-22-4-335, PubMed 3098977

von der Lippe E, Frøland S, Rollag H, Degre M (1986)
Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages
Acta Pathol Microbiol Immunol Scand B, 94 (5), 343-6
DOI 10.1111/j.1699-0463.1986.tb03064.x, PubMed 3098042

Mustafa AS, Kvalheim G, Degre M, Godal T (1986)
Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production
Infect Immun, 53 (3), 491-7
DOI 10.1128/iai.53.3.491-497.1986, PubMed 2427449

Bruserud O, Degré M, Thorsby E (1986)
Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin
Acta Pathol Microbiol Immunol Scand C, 94 (2), 51-5
DOI 10.1111/j.1699-0463.1986.tb02089.x, PubMed 3090859

Livden JK, Bjerke JR, Degre M, Matre R (1986)
The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis
Br J Dermatol, 114 (2), 217-25
DOI 10.1111/j.1365-2133.1986.tb02800.x, PubMed 2418865

Degré M, Holberg-Petersen M (1986)
Influence of a carcinogenic agent, 7.12 dimethylbenz (alpha) anthracene (DMBA), on production of interferon alpha/beta in murine and human cells
Acta Pathol Microbiol Immunol Scand B, 94 (1), 51-5
DOI 10.1111/j.1699-0463.1986.tb03019.x, PubMed 3014815

DEGRE M (1986)
INTERACTION BETWEEN VIRAL AND BACTERIAL-INFECTIONS IN THE RESPIRATORY-TRACT
Scand. J. Infect. Dis. (49), 140-145

Siebke JC, von der Lippe B, Hansson BG, Nordenfelt E, Degré M (1986)
Prevalence and clinical effects of delta agent. Infections in Norwegian population subgroups
Scand J Infect Dis, 18 (1), 33-6
DOI 10.3109/00365548609032303, PubMed 3961420

Kjeldsberg E, Rollag H, Lund H, Holberg-Pettersen M, Degré M (1985)
Effect of gamma interferon on spreading of mouse peritoneal macrophages on solid surfaces
Acta Pathol Microbiol Immunol Scand B, 93 (3), 165-70
DOI 10.1111/j.1699-0463.1985.tb02871.x, PubMed 3929557

Qvigstad E, Onsrud M, Degré M, Skaug K (1985)
Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma
Gynecol Oncol, 20 (2), 184-9
DOI 10.1016/0090-8258(85)90140-4, PubMed 2982703

Bukholm G, Holberg-Petersen M, Degré M (1985)
Invasiveness of Salmonella typhimurium in HEp-2 cell cultures pretreated with UV-inactivated coxsackie virus
Acta Pathol Microbiol Immunol Scand B, 93 (1), 61-5
DOI 10.1111/j.1699-0463.1985.tb02852.x, PubMed 2984878

Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO (1985)
Vaccination of children with malignant disease against varicella
Postgrad Med J, 61 Suppl 4, 85-92
PubMed 3014484

Bukholm G, Degré M (1985)
Effect of human gamma interferon on invasiveness of Salmonella typhimurium in HEp-2 cell cultures
J Interferon Res, 5 (1), 45-53
DOI 10.1089/jir.1985.5.45, PubMed 3921632

Slørdahl SH, Lie SO, Wiger D, Winsnes R, Degre M, Strømøy T, Thorsby E (1984)
[Vaccination of immunosuppressed children against varicella]
Tidsskr Nor Laegeforen, 104 (30), 2086-9
PubMed 6095484

Siebke JC, Degré M (1984)
Prevalence of viral hepatitis in the staff in Norwegian anaesthesiology units
Acta Anaesthesiol Scand, 28 (5), 549-53
DOI 10.1111/j.1399-6576.1984.tb02117.x, PubMed 6496015

Degré M, Siebke JC, Frøland SS (1984)
[Prevention of hepatitis B by vaccination]
Tidsskr Nor Laegeforen, 104 (27), 1906-7
PubMed 6515608

Rollag H, Degré M, Sonnenfeld G (1984)
Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages
Scand J Immunol, 20 (2), 149-55
DOI 10.1111/j.1365-3083.1984.tb00988.x, PubMed 6236548

Bukholm G, Berdal BP, Haug C, Degré M (1984)
Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice
Infect Immun, 45 (1), 62-6
DOI 10.1128/iai.45.1.62-66.1984, PubMed 6376362

Bukholm G, Degré M (1984)
Invasiveness of Salmonella typhimurium in HEp-2 cell cultures preinfected with Coxsackie B 1 virus
Acta Pathol Microbiol Immunol Scand B, 92 (1), 45-51
DOI 10.1111/j.1699-0463.1984.tb02792.x, PubMed 6324532

BJERKE JR, DEGRE M, HAUKENES G, KROGH HK, LIVDEN JK, MATRE R (1984)
T-CELLS, INTERFERONS AND RETROVIRUS-LIKE PARTICLES IN PSORIATIC LESIONS
Acta Derm.-Venereol. (113), 29-33

Vinje O, Førre O, Degre M, Møller P (1984)
Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis)
Scand J Rheumatol, 13 (4), 297-302
DOI 10.3109/03009748409111299, PubMed 6441246

Degré M (1984)
[Interferon--recent developments at basic and application levels]
Nord Med, 99 (3), 76-7, 71
PubMed 6203095

Degré M, Glasgow LA (1983)
Establishment and preliminary characterization of a cell line persistently infected with Newcastle disease virus
Acta Pathol Microbiol Immunol Scand B, 91 (6), 389-94
DOI 10.1111/j.1699-0463.1983.tb00065.x, PubMed 6324529

DeGré M, Mellbye OJ, Clarke-Jenssen O (1983)
Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders
Ann Rheum Dis, 42 (6), 672-6
DOI 10.1136/ard.42.6.672, PubMed 6418086

Ritland S, Blomhoff JP, Degre M (1983)
[Hepatitis B virus--hepatocellular carcinoma]
Tidsskr Nor Laegeforen, 103 (33), 2237-9
PubMed 6318382

Degré M, Belsnes K, Rollag H, Beck S, Sonnenfeld G (1983)
Influence of the genotype of mice on the effect of interferon on phagocytic activity of macrophages
Proc Soc Exp Biol Med, 173 (1), 27-31
DOI 10.3181/00379727-173-41604, PubMed 6344094

Bjerke JR, Livden JK, Degré M, Matre R (1983)
Interferon in suction blister fluid from psoriatic lesions
Br J Dermatol, 108 (3), 295-9
DOI 10.1111/j.1365-2133.1983.tb03967.x, PubMed 6187354

Degré M (1983)
[Immunological defense factors against viral infections]
Tidsskr Nor Laegeforen, 103 (3), 177-8
PubMed 6845309

Degré M (1983)
[Vaccines against cytomegalovirus infection]
Tidsskr Nor Laegeforen, 103 (3), 236-7
PubMed 6302943

Rollag H, Degré M (1982)
Effect of beta-interferon on in vitro spreading of mouse peritoneal macrophages
Acta Pathol Microbiol Immunol Scand B, 90 (6), 389-95
DOI 10.1111/j.1699-0463.1982.tb00136.x, PubMed 7168315

Dobloug JH, Førre O, Kvien TK, Egeland T, Degré M (1982)
Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis
Ann Rheum Dis, 41 (5), 490-4
DOI 10.1136/ard.41.5.490, PubMed 6181746

Lingaas E, Degré M (1982)
[Screening for rubella antibodies in newly employed women at the National Hospital]
Tidsskr Nor Laegeforen, 102 (25), 1272-3
PubMed 7164071

Melby K, Midtvedt T, Degré M (1982)
Effect of human leukocyte interferon on phagocytic activity of polymorphonuclear leukocytes
Acta Pathol Microbiol Immunol Scand B, 90 (3), 181-4
DOI 10.1111/j.1699-0463.1982.tb00102.x, PubMed 6181651

Rollag H, Mørland B, Degré M (1982)
Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages
Acta Pathol Microbiol Immunol Scand B, 90 (2), 113-8
DOI 10.1111/j.1699-0463.1982.tb00091.x, PubMed 6177190

Siebke JC, Degré M, Ritland S, Enger SC (1982)
Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway
Am J Epidemiol, 115 (2), 185-91
DOI 10.1093/oxfordjournals.aje.a113290, PubMed 7058777

Degré M, Rollag H (1982)
Effect of murine beta-interferon preparation on phagocytosis and cyclic AMP levels in mouse peritoneal macrophages
J Interferon Res, 2 (2), 151-7
DOI 10.1089/jir.1982.2.151, PubMed 6288813

Degre M, Glasgow LA (1981)
Effect of interferon on cyclic adenosine monophosphate levels in cells
Antiviral Res, 1 (3), 185-92
DOI 10.1016/0166-3542(81)90007-3, PubMed 6175278

Rollag H, Degré M (1981)
Effect of interferon preparations on the uptake of non-opsonized Escherichia coli by mouse peritoneal macrophages
Acta Pathol Microbiol Scand B, 89 (3), 153-9
DOI 10.1111/j.1699-0463.1981.tb00169_89b.x, PubMed 6171991

Egge K, Djupesland G, Modalsli B, Degré M (1981)
Severe hearing loss and retinopathy in children: on the possible association with rubella virus infection
Scand Audiol, 10 (2), 75-9
DOI 10.3109/01050398109076165, PubMed 7280544

Olstad R, Degré M, Seljelid R (1981)
Production of immune interferon (type II) in cocultures of mouse peritoneal macrophages and syngeneic tumour cells
Scand J Immunol, 13 (6), 605-8
DOI 10.1111/j.1365-3083.1981.tb00175.x, PubMed 6171873

Degré M, Sonnenfeld G, Rollag H, Mørland B (1981)
Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages
J Interferon Res, 1 (4), 505-12
DOI 10.1089/jir.1981.1.505, PubMed 6180084

Degré M (1980)
Antiviral and cell multiplication inhibitory activities of mouse interferon poreparations tested on an interferon sensitive murine sarcoma cell line
Acta Pathol Microbiol Scand B, 88 (4), 219-23
DOI 10.1111/j.1699-0463.1980.tb02631.x, PubMed 6158254

Degré M, Rollag H (1980)
Pathogenesis of Sendasi virus infection in mice. On the possible role of interferon on the development of disease
Acta Pathol Microbiol Scand B, 88 (3), 177-81
PubMed 6160724

Degré M, Rollag H (1979)
Screening for rubella antibodies by a single radial haemolysis test
NIPH Ann, 2 (2), 25-30
PubMed 398458

Degré M, Rollag H (1979)
Influence of interferon on the in vivo phagocytic activity of reticuloendothelial system cells
J Reticuloendothel Soc, 25 (5), 489-93
PubMed 458780

Djupesland G, Flottorp G, Degré M, Stien R, Skrede S (1979)
Cochlear hearing loss and viral infection
Acta Otolaryngol, 87 (3-4), 247-54
DOI 10.3109/00016487909126416, PubMed 375666

Degré M, Bukholm G, Lund EE, Djupesland G (1978)
Attempts to isolate virus from human trigeminal and facial ganglions
Med Microbiol Immunol, 166 (1-4), 151-6
DOI 10.1007/BF02121144, PubMed 214678

Degré M (1978)
Effect of human leukocyte interferon on the permeability of the cytoplasma membrane of cultured cells
Acta Pathol Microbiol Scand B, 86B (5), 303-7
DOI 10.1111/j.1699-0463.1978.tb00048.x, PubMed 716922

Degré M, Wilhelmsen KW (1978)
[Interferons. Biological principal and practical application]
Tidsskr Nor Laegeforen, 98 (24), 1152-4
PubMed 684722

Degré M (1978)
Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon
Proc Soc Exp Biol Med, 157 (2), 253-5
PubMed 202975

Djupesland G, Degré M, Stien R, Skrede S (1977)
Acute peripheral facial palsy. Part of a cranial polyneuropathy?
Arch Otolaryngol, 103 (11), 641-4
DOI 10.1001/archotol.1977.00780280041004, PubMed 200210

Degré M, Gláz ET (1977)
Interferon induction in human cell cultures by small molecular inducers (tilorone and acridines)
Acta Pathol Microbiol Scand B, 85 (3), 189-94
DOI 10.1111/j.1699-0463.1977.tb01695.x, PubMed 888701

Degré M, Hovig B, Midtvedt T (1977)
[Can the transport agar method be used for determination of resistance in urinary tract infections?]
Tidsskr Nor Laegeforen, 97 (5), 248-50
PubMed 841561

Rollag H, degré M (1976)
Effect of antibiotics on interferon production in mice
Acta Pathol Microbiol Scand B, 84B (6), 369-72
DOI 10.1111/j.1699-0463.1976.tb01954.x, PubMed 998256

Degré M, Hovig T (1976)
Functional and ultrastructural studies of the effects of human interferon on cell membranes of in vitro cultured cells
Acta Pathol Microbiol Scand B, 84B (6), 347-58
DOI 10.1111/j.1699-0463.1976.tb01952.x, PubMed 187008

Degre M, Vandvik B (1976)
[Nobel prizes 1976 in physiology and medicine]
Tidsskr Nor Laegeforen, 92 (33), 1754-5
PubMed 996844

Dahl H, Degré M (1976)
Human interferon and cell growth inhibition. I. Inhibitory effect of human interferon on the growth rate of cultured human cells
Acta Pathol Microbiol Scand B, 84B (5), 285-92
DOI 10.1111/j.1699-0463.1976.tb01939.x, PubMed 184682

Dahl H, Degré M (1976)
The effect of ascorbic acid on production of human interferon and the antiviral activity in vitro
Acta Pathol Microbiol Scand B, 84B (5), 280-4
DOI 10.1111/j.1699-0463.1976.tb01938.x, PubMed 970135

Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1976)
Viral infection as a cause of acute peripheral facial palsy
Arch Otolaryngol, 102 (7), 403-6
DOI 10.1001/archotol.1976.00780120051005, PubMed 938319

Degré M, Dahl H, Vandvik B (1976)
Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders
Acta Neurol Scand, 53 (2), 152-60
DOI 10.1111/j.1600-0404.1976.tb04333.x, PubMed 1266564

Vandvik B, Norrby E, Nordal HJ, Degré M (1976)
Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis
Scand J Immunol, 5 (8), 979-92
DOI 10.1111/j.1365-3083.1976.tb03050.x, PubMed 996452

DAHL H, DEGRE M (1976)
EFFECT OF ASCORBIC-ACID ON PRODUCTION OF HUMAN INTERFERON AND ANTIVIRAL ACTIVITY INVITRO
ACTA PATH MICRO IM B, 84 (5), 280-284

Dahl H, Degre M (1975)
Separation of antiviral activity of human interferon from cell growth inhibitory effect
Nature, 257 (5529), 799-800
DOI 10.1038/257799a0, PubMed 1186865

Vandvik B, Degré M (1975)
Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system
J Neurol Sci, 24 (2), 201-19
DOI 10.1016/0022-510x(75)90233-6, PubMed 1113135

Rollag H, Berdal BP, Bergan T, Degré M, Hovig B, Midtvedt T (1975)
[Letter: Microstix and N-labstix "Ames"--unsafe for proving bacteriuria]
Tidsskr Nor Laegeforen, 95 (3), 198
PubMed 1118846

Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1975)
The role of viral infection in acute peripheral facial palsy
Acta Otolaryngol, 79 (3-4), 221-7
DOI 10.3109/00016487509124677, PubMed 1136761

DEGRE M, ELGJO K (1975)
INFLUENCE OF SYNTHETIC POLYNUCLEOTIDES AND INTERFERON ON INVITRO GROWTH OF CELLS DERIVED FROM A MOUSE SARCOMA
ACTA PATH MICRO IM A, 1974 248, 61-68

Elgjo K, Degré M (1975)
Polyinosinic-polycytidylic acid: inhibition of cell proliferation in carcinogen-treated epidermis and in carcinogen-induced skin tumors in mice
J Natl Cancer Inst, 54 (1), 219-21
DOI 10.1093/jnci/54.1.219, PubMed 1113302

Degré M (1974)
Influence of exogenous interferon on the peripheral white blood cell count in mice
Int J Cancer, 14 (6), 699-703
DOI 10.1002/ijc.2910140602, PubMed 4463167

Degré M, Dahl H (1974)
Interferon production and prevention of viral infections in mice by components of a mixed bacterial vaccine
Acta Pathol Microbiol Scand B Microbiol Immunol, 82 (6), 904-10
DOI 10.1111/j.1699-0463.1974.tb02390.x, PubMed 4549161

DEGRE M, DAHL H (1974)
INTERFERON-PRODUCTION AND PREVENTION OF VIRAL-INFECTIONS IN MICE BY COMPONENTS OF A MIXED BACTERIAL VACCINE
ACTA PATH MICRO IM B, B 82 (6), 904-910

Degré M, Elgjo K (1974)
Influence of synthetic polynucleotides and interferon on in vitro growth of cells derived from a mouse sarcoma
Acta Pathol Microbiol Scand Suppl, Suppl 248, 61-8
PubMed 4217556

Degré M, Midtvedt T (1973)
Effect of standard bacterial vaccine on influenza virus infection and interferon production in germfree mice
Acta Pathol Microbiol Scand B Microbiol Immunol, 81 (6), 782-6
DOI 10.1111/j.1699-0463.1973.tb02277.x, PubMed 4521974

Degré M, Dahl H (1973)
Enhanced effect of repeated administration of bacterial vaccine against viral respiratory infection
Infect Immun, 7 (5), 771-6
DOI 10.1128/iai.7.5.771-776.1973, PubMed 4357990

Degré M (1973)
Influence of polyinosinic: polycytidylic acid on the circulating white blood cells in mice
Proc Soc Exp Biol Med, 142 (4), 1087-91
PubMed 4694806

Vandvik B, Froland SS, Hoyeraal HM, Stien R, Degré M (1973)
Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor
Scand J Immunol, 2 (4), 367-74
DOI 10.1111/j.1365-3083.1973.tb02045.x, PubMed 4797728

DEGRE M, MIDTVEDT T (1973)
EFFECT OF STANDARD BACTERIAL VACCINE ON INFLUENZA-VIRUS INFECTION AND INTERFERON-PRODUCTION IN GERMFREE MICE
ACTA PATH MICRO IM B, B 81 (6), 782-786

Degre M (1972)
[Slow virus infections]
Tidsskr Nor Laegeforen, 92 (11), 783-5
PubMed 5063782

Degré M (1972)
[Possible interaction between viral and bacterial agents in respiratory tract infections]
Tidsskr Nor Laegeforen, 92 (8), 556-8
PubMed 5021893

Degré M (1972)
Effect of a standard bacterial vaccine on infection with an obligate intracellular parasite (Toxoplasma gondii) in mice
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 478-80
DOI 10.1111/j.1699-0463.1972.tb00064.x, PubMed 4505774

Degré M, Vandvik B, Hovig T (1972)
Subacute sclerosing panencephalitis: isolation and ultrastructural characterization of a measles-like virus from brain obtained at autopsy
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (5), 713-28
DOI 10.1111/j.1699-0463.1972.tb00199.x, PubMed 4629361

Dahl H, Degré M (1972)
A micro assay for mouse and human interferon
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (6), 863-70
DOI 10.1111/j.0365-5563.1973.tb00012.x, PubMed 4345661

DAHL H, DEGRE M (1972)
MICRO ASSAY FOR MOUSE AND HUMAN INTERFERON
ACTA PATH MICRO IM B, B 80 (6), 863-870

Dahl H, Degré M (1972)
Preventive effect of a nonviral interferon inducer, a bacterial vaccine, on experimental influenza in mice
Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 467-74
DOI 10.1111/j.1699-0463.1972.tb00062.x, PubMed 4505773

Degre M, Dahl H (1971)
Production of an interferon-like agent following inoculation with bacterial vaccine
Proc Soc Exp Biol Med, 137 (1), 233-6
DOI 10.3181/00379727-137-35551, PubMed 4325773

Degré M, Midtvedt T (1971)
Respiratory infection with parainfluenza 1, Sendai virus in gnotobiotic and conventional mice
Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (1), 123-4
DOI 10.1111/j.1699-0463.1971.tb00042.x, PubMed 4324935

Degré M (1971)
Synergistic effect in viral-bacterial infection. 5. Functional studies on the role of the ciliary activity in the mouse trachea
Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (2), 137-41
PubMed 4325914

Degré M (1971)
Synergistic effect in viral-bacterial infection. 4. The leukocyte response to parainfluenza virus infection in the respiratory tract of mice, and the influence of antibiotics on the development of infection
Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (1), 88-94
PubMed 4324936

Degré M, Solberg LA (1971)
Synergistic effect in viral-bacterial infection. 3. Histopathological changes in the trachea of mice following viral and bacterial infection
Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (2), 129-36
PubMed 4325913

Degré M, Elgjo K (1971)
Methylcholanthrene-induced skin carcinogenesis modified by treatment with polyinosinic:polycytidylic acid (poly I:C)
Acta Pathol Microbiol Scand A, 79 (6), 687-8
PubMed 5123526

Skjorten F, Kierulf PB, Degré M (1970)
Formation of hyaline microthrombi in the mouse. Evidence for dependence on the fibrinolytic system
Acta Pathol Microbiol Scand A, 78 (3), 351-61
PubMed 5507260

Degré M (1970)
Synergistic effect in viral-bacterial infection. 2. Influence of viral infection on the phagocytic ability of alveolar macrophages
Acta Pathol Microbiol Scand B Microbiol Immunol, 78 (1), 41-50
PubMed 4316170

Degré M (1970)
[Quantitative and semiquantitative methods for the diagnosis of bacteriuria]
Tidsskr Nor Laegeforen, 90 (1), 27-30
PubMed 5426183

Degré M (1969)
Phagocytic and bactericidal activities of peritoneal and alveolar macrophages from mice
J Med Microbiol, 2 (3), 353-7
DOI 10.1099/00222615-2-3-353, PubMed 5314333

Degré M, Glasgow LA (1968)
Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza
J Infect Dis, 118 (5), 449-62
DOI 10.1093/infdis/118.5.449, PubMed 4302684

Degré M (1968)
[Etiological disgnosis of purulent meningitis]
Tidsskr Nor Laegeforen, 88 (12), 1091-4
PubMed 4387023

Degré M (1967)
Reproducibility of staphylococcal bacteriophage types by use of different concentrations of bacteriophage
Appl Microbiol, 15 (4), 907-11
DOI 10.1128/am.15.4.907-911.1967, PubMed 4227800

Degré M (1966)
Simple quantitative methods in the bacteriological diagnosis of urinary tract infection
J Oslo City Hosp, 16 (8), 184-96
PubMed 5329982

Degré M (1966)
Bacteriophage typing of Staphylococcus aureus using a single concentration of phage (100 x RTD)
Acta Pathol Microbiol Scand, 66 (1), 105-12
DOI 10.1111/apm.1966.66.1.105, PubMed 4224085

Degrè M, Ulstrup JC (1965)
[Bacteriological studies on otitis media. 1-year case material]
Tidsskr Nor Laegeforen, 85 (12), 994-7
PubMed 5864803

Daae L, Degré M (1965)
[Bacteriological studies of urine. A comparison between washed down specimens and catheterized specimens from bedridden women]
Tidsskr Nor Laegeforen, 85 (12), 1003-5
PubMed 5865811

DEGRE M (1964)
[DISINFECTION OF THE DUMMY FIGURES USED IN TRAINING FOR MOUTH-TO-MOUTH RESPIRATION METHODS]
Tidsskr Nor Laegeforen, 84, 1112-4
PubMed 14230470

DEGRE M (1962)
[Anaphylactic reaction to carisoprodol]
Tidsskr Nor Laegeforen, 82, 1589
PubMed 14026463

TIGYI A, LISSAK K, DEGRE M, PETER K (1957)
[Role of neurohormonal factors in pathological changes in lungs]
Magy Tud, 8 (1-2), 86-9
PubMed 13450585

Review articles

Degré M, Sagedal S, Rollag H (2005)
Viral infections in immunocompromised patients. A review
Acta Microbiol Immunol Hung, 52 (3-4), 351-62
DOI 10.1556/AMicr.52.2005.3-4.7, PubMed 16400875

Reesink HW, Engelfriet CP, Tegtmeier GE, O'Riordan J, Eglin R, Barbara JA, Flanagan P, Lin CK, Rawlinson W, Muylle L, Wendel S, Biagini S, Lazar AE, Krusius T, Alitupa E, Grillner L, Preiser W, Doerr HW, Brand A, Zupanska B, Brojer E, Degré M (2002)
Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
Vox Sang, 83 (1), 72-87
DOI 10.1046/j.1423-0410.2002.t01-1-01851.x, PubMed 12100393

Fiane AE, Mollnes TE, Degré M (2000)
Pig endogenous retrovirus--a threat to clinical xenotransplantation?
APMIS, 108 (4), 241-50
DOI 10.1034/j.1600-0463.2000.d01-51.x, PubMed 10843410

Degré M (1996)
Interferons and other cytokines in bacterial infections
J Interferon Cytokine Res, 16 (6), 417-26
DOI 10.1089/jir.1996.16.417, PubMed 8807494

Degré M (1995)
[Transmissible spongiform encephalopathies--an unconventional contagious agent]
Tidsskr Nor Laegeforen, 115 (25), 3137-40
PubMed 8539696

Degré M (1991)
[Antiviral agents for the systemic treatment of herpesvirus infections]
Tidsskr Nor Laegeforen, 111 (21), 2663-4
PubMed 1658971

Degré M (1986)
Interaction between viral and bacterial infections in the respiratory tract
Scand J Infect Dis Suppl, 49, 140-5
PubMed 2434989

Degré M, Rollag H (1981)
On the possible role of interferon in infections with non-viral agents
Tex Rep Biol Med, 41, 388-94
PubMed 6184830

Degré M (1974)
[Virus as a cause of leukemia and blood cell disease in man]
Tidsskr Nor Laegeforen, 94 (32), 2205-7
PubMed 4140582

Degré M (1973)
[Acute effects of cigarette smoke on the respiratory tract]
Tidsskr Nor Laegeforen, 93 (6), 362-5
PubMed 4572673